InvestorsHub Logo
Followers 15
Posts 1324
Boards Moderated 0
Alias Born 07/23/2013

Re: hanscott post# 25548

Thursday, 01/17/2019 8:13:03 AM

Thursday, January 17, 2019 8:13:03 AM

Post# of 34575

Marker Therapeutics to Present at the Phacilitate Leaders World & World Stem Cell Summit 2019

Houston, TX – January 17, 2019 – Marker Therapeutics, Inc. (Nasdaq:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced that its President and CEO, Peter L. Hoang, will present a corporate overview at the upcoming Phacilitate Leaders World & World Stem Cell Summit 2019 on Wednesday, January 23, 2019.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News